In silico tools predict effects of drugs on bone remodelling
- PMID: 32581392
- DOI: 10.1038/s41584-020-0457-6
In silico tools predict effects of drugs on bone remodelling
Comment on
-
In silico experiments of bone remodeling explore metabolic diseases and their drug treatment.Sci Adv. 2020 Mar 6;6(10):eaax0938. doi: 10.1126/sciadv.aax0938. eCollection 2020 Mar. Sci Adv. 2020. PMID: 32181336 Free PMC article.
References
-
- Seeman, E. & Martin, T. J. Antiresorptive and anabolic agents in the prevention and reversal of bone fragility. Nat. Rev. Rheumatol. 15, 225–236 (2019). - DOI
-
- Kameo, Y., Miya, Y., Hayashi, M., Nakashima, T. & Adachi, T. In silico experiments of bone remodeling explore metabolic diseases and their drug treatment. Sci. Adv. 6, eaax0938 (2020). - DOI
-
- Gerhard, F. A., Webster, D. J., van Lenthe, G. H. & Müller, R. In silico biology of bone modelling and remodelling: adaptation. Philos. Trans. A Math. Phys. Eng. Sci. 367, 2011–2030 (2009). - DOI
-
- Riggs, M. M. & Cremers, S. Pharmacometrics and systems pharmacology for metabolic bone diseases. Br. J. Clin. Pharmacol. 85, 1136–1146 (2019). - DOI
-
- US Food and Drug Administration. Reporting of Computational Modeling Studies in Medical Device Submissions https://www.fda.gov/regulatory-information/search-fda-guidance-documents... (2016).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources